Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by whippeton Jul 05, 2017 10:06am
114 Views
Post# 26434770

getting involved in the US

getting involved in the US


Good morning,

this news is great to see.  ADK has announced the strategy they are gonna use to develop the US market. 
<
this opens the door  to a lot of opportunities. The company now knows how to do it, and how to profit from it. 
<
short term, might not seem like it but over the next few months, it as the possibility to develop the US market in big ways, one state at the time.  And i expect ADK to grow rapidly in that country when those eye specialists start speading the word on our technology, the efficiency rate, the time it takes to get results, etc.
i am very confident that in the long run this is gonna bring very good revenues. 
<
Dont forget, those clinics already have all the equipment , cameras, computers, etc....   so we dont have any major  investments to make.
at .15, i feel it's cheap.  
<
I am also very confident we should see the Mexico announcement in the next few weeks. Governments always take a long time to move. But the picture we saw last week sais it all.
<
I wish we could ear more developments on the cardiovascular side. 
The fact that Hebert continues to accumulate, to me,  is a sign that the companie's future is gonna be GREAT.
Just my opinion.

good luck to all

whippet

Bullboard Posts